Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 259

The DOI matches its Crossref record.

Dopamine receptor expression on human T- and B-lymphocytes, monocytes, neutrophils, eosinophils and NK cells: a flow cytometric study

McKenna, F, McLaughlin, P.J, Lewis, B.J, Sibbring, G.C, Cummerson, J.A, Bowen-Jones, D, Moots, R.J·2002·Journal of Neuroimmunology
DOI 10.1016/s0165-5728(02)00280-1
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0165-5728(02)00280-1

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 44

  1. Amenta, 1999, Dopamine D2-like receptors on human peripheral blood lymphocytes: a radioligand binding assay and immunocytochemical study, J. Auton. Pharmacol., 19, 151, 10.1046/j.1365-2680.1999.00135.x · DOI
  2. Barbanti, 1996, Increased density of dopamine D5 receptor in peripheral blood lymphocytes of migraineurs: a marker for migraine?, Neurosci. Lett., 207, 73, 10.1016/0304-3940(96)12491-5 · doi:10.1016/0304-3940(96)12491-5
  3. Barili, 1996, Age-dependent changes in the expression of dopamine receptor subtypes in human peripheral blood lymphocytes, J. Neuroimmunol., 71, 45, 10.1016/S0165-5728(96)00127-0 · DOI
  4. Bergquist, 1998, Identification of catecholamines in the immune system by electrospray ionization mass spectrometry, Rapid Commun. Mass Spectrom., 12, 683, 10.1002/(SICI)1097-0231(19980615)12:11<683::AID-RCM218>3.0.CO;2-N · DOI
  5. Bergquist, 2000, Nuclear factor-kappa B is involved in the catecholaminergic suppression of immunocompetent cells, Ann. N.Y. Acad. Sci., 917, 281, 10.1111/j.1749-6632.2000.tb05394.x · DOI
  6. Bondy, 1996, Identification of dopamine D4 receptor mRNA in circulating human lymphocytes using nested polymerase chain reaction, J. Neuroimmunol., 71, 139, 10.1016/S0165-5728(96)00148-8 · DOI
  7. Boukhris, 1988, Differential effect of mixed D1/D2 and selective D2 dopaminergic antagonists on mouse T and B lymphocyte proliferation and interleukin production in vitro, Immunopharmacol. Immunotoxicol., 10, 501, 10.3109/08923978809006451 · doi:10.3109/08923978809006451
  8. Chio, 1994, Activation of heterologously expressed D3 dopamine receptors: comparison with D2 dopamine receptors, Mol. Pharmacol., 45, 51
  9. Cosentino, 2000, HPLC-ED measurement of endogenous catecholamines in human immune cells and hematopoietic cell lines, Life Sci., 68, 283, 10.1016/S0024-3205(00)00937-1 · DOI
  10. Garza, 1993, Characterization of a (+)-azidophenazocine-sensitive sigma receptor on splenic lymphocytes, J. Immunol., 151, 4672, 10.4049/jimmunol.151.9.4672 · doi:10.4049/jimmunol.151.9.4672
  11. Gingrich, 1993, Recent advances in the molecular biology of dopamine receptors, Annu. Rev. Neurosci., 16, 299, 10.1146/annurev.ne.16.030193.001503 · DOI · Paper page
  12. Griffiths, 1992, The sequestration of [3H]spiperone by lymphocytes in schizophrenics and their first-degree relatives: a limited vulnerability marker?, J. Psychiatr. Res., 26, 77, 10.1016/0022-3956(92)90018-J · doi:10.1016/0022-3956(92)90018-j
  13. Hasko, 2002, Dopamine suppresses IL-12 p40 production by lipopolysaccharide-stimulated macrophages via a beta-adrenoceptor-mediated mechanism, J. Neuroimmunol., 122, 34, 10.1016/S0165-5728(01)00459-3 · DOI
  14. Josefsson, 1996, Catecholamines are synthesized by mouse lymphocytes and regulate function of these cells by induction of apoptosis, Immunology, 88, 140, 10.1046/j.1365-2567.1996.d01-653.x · DOI · Paper page
  15. Lachowicz, 1997, Molecular characteristics of mammalian dopamine receptors, Pharmacol. Toxicol., 81, 105, 10.1111/j.1600-0773.1997.tb00039.x · DOI
  16. Levite, 2001, Dopamine interacts directly with its D3 and D2 receptors on normal human T cells, and activates beta1 integrin function, Eur. J. Immunol., 31, 3504, 10.1002/1521-4141(200112)31:12<3504::AID-IMMU3504>3.0.CO;2-F · DOI
  17. Liu, 1996, Haloperidol and spiperone potentiate murine splenic B cell proliferation, Immunopharmacology, 34, 147, 10.1016/0162-3109(96)00120-8 · doi:10.1016/0162-3109(96)00120-8
  18. McCarty, 2001, Upregulation of lymphocyte apoptosis as a strategy for preventing and treating autoimmune disorders: a role for whole-food vegan diets, fish oil and dopamine agonists, Med. Hypotheses, 57, 258, 10.1054/mehy.2000.1318 · DOI
  19. Mena, 1995, Effects of calcium antagonists on the dopamine system, Clin. Neuropharmacol., 18, 410, 10.1097/00002826-199510000-00004 · DOI
  20. Missale, 1998, Dopamine receptors: from structure to function, Physiol. Rev., 78, 189, 10.1152/physrev.1998.78.1.189 · DOI · Paper page
  21. Mizruchin, 1999, Comparison of the effects of dopaminergic and serotonergic activity in the CNS on the activity of the immune system, J. Neuroimmunol., 101, 201, 10.1016/S0165-5728(99)00144-7 · DOI
  22. Moots, 1999, Old drug, new tricks: haloperidol inhibits secretion of proinflammatory cytokines, Ann. Rheum. Dis., 58, 585, 10.1136/ard.58.9.585 · DOI
  23. Morkawa, 1993, Immunosuppressive property of bromocriptine on human B lymphocyte function in vitro, Clin. Exp. Immunol., 93, 200, 10.1111/j.1365-2249.1993.tb07966.x · DOI
  24. Moulding, 2001, BCL-2 family expression in human neutrophils during delayed and accelerated apoptosis, J. Leukoc. Biol., 70, 783, 10.1189/jlb.70.5.783 · DOI · Paper page
  25. Nagai, 1993, Expression of the D3 dopamine receptor gene and a novel variant transcript generated by alternative splicing in human peripheral blood lymphocytes, Biochem. Biophys. Res. Commun., 194, 368, 10.1006/bbrc.1993.1829 · DOI
  26. Pilon, 1994, Functional coupling of the human dopamine D3 receptor in a transfected NG 108-15 neuroblastoma–glioma hybrid cell line, Eur. J. Pharmacol., 268, 129, 10.1016/0922-4106(94)90182-1 · DOI
  27. Ricci, 1997, Dopamine D3 receptor in peripheral mononuclear cells of essential hypertensives, Hypertension, 30, 1566, 10.1161/01.HYP.30.6.1566 · doi:10.1161/01.hyp.30.6.1566
  28. Ricci, 1998, Labeling of dopamine D3 and D4 receptor subtypes in human peripheral blood lymphocytes with [3H]7-OH-DPAT: a combined radioligand binding assay and immunochemical study, J. Neuroimmunol., 92, 191, 10.1016/S0165-5728(98)00207-0 · DOI
  29. Ricci, 1999, Dopamine D1-like receptor subtypes in human peripheral blood lymphocytes, J. Neuroimmunol., 96, 234, 10.1016/S0165-5728(99)00042-9 · DOI
  30. Rocheville, 2000, Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity, Science, 288, 154, 10.1126/science.288.5463.154 · DOI · Paper page
  31. Saha, 2001, Circulating dopamine level, in lung carcinoma patients, inhibits proliferation and cytotoxicity of CD4+ and CD8+ T cells by D1 dopamine receptors: an in vitro analysis, Int. J. Immunopharmacol., 1, 1363, 10.1016/S1567-5769(01)00068-6 · DOI
  32. Santambrogio, 1993, Dopamine receptors on human T- and B-lymphocytes, J. Neuroimmunol., 45, 113, 10.1016/0165-5728(93)90170-4 · DOI
  33. Sawatzky, 2002, Eosinophil adhesion to cholinergic nerves via ICAM-1 and VCAM-1 and associated eosinophil degranulation, Am. J. Physiol., Lung Cell. Mol. Physiol., 282, L1279, 10.1152/ajplung.00279.2001 · DOI
  34. Scarselli, 2001, D2/D3 dopamine receptor heterodimers exhibit unique functional properties, J. Biol. Chem., 276, 30308, 10.1074/jbc.M102297200 · DOI · Paper page
  35. Seeman, 1994, Dopamine receptor pharmacology, Trends Pharmacol. Sci., 15, 264, 10.1016/0165-6147(94)90323-9 · DOI · Paper page
  36. Sibley, 1992, Molecular biology of dopamine receptors, Trends Pharmacol. Sci., 13, 61, 10.1016/0165-6147(92)90025-2 · DOI · Paper page
  37. Sookhai, 1999, Dopamine induces neutrophil apoptosis through a dopamine D-1 receptor-independent mechanism, Surgery, 126, 314, 10.1016/S0039-6060(99)70171-6 · DOI
  38. Swarzenski, 1994, Morphogenic potentials of D2, D3, and D4 dopamine receptors revealed in transfected neuronal cell lines, Proc. Natl. Acad. Sci. U. S. A., 91, 649, 10.1073/pnas.91.2.649 · DOI
  39. Takahashi, 1992, Human peripheral blood lymphocytes express D5 dopamine receptor gene and transcribe the two pseudogenes, FEBS Lett., 314, 23, 10.1016/0014-5793(92)81452-R · DOI
  40. Tarazona, 1995, Chlorpromazine amplifies macrophage-dependent IL-10 production in vivo, J. Immunol., 154, 861, 10.4049/jimmunol.154.2.861 · DOI
  41. Tsao, 1998, Inhibition of immune cell proliferation with haloperidol and relationship of tyrosine hydroxylase expression to immune cell growth, Life Sci., 62, PL335, 10.1016/S0024-3205(98)00170-2 · doi:10.1016/s0024-3205(98)00170-2
  42. Vallone, 2000, Structure and function of dopamine receptors, Neurosci. Biobehav. Rev., 24, 125, 10.1016/S0149-7634(99)00063-9 · DOI · Paper page
  43. Vile, 1996, D2-like dopamine receptors are not detectable on human peripheral blood lymphocytes, Biol. Psychiatry, 40, 881, 10.1016/0006-3223(95)00498-X · DOI
  44. Weihe, 1991, Molecular anatomy of the neuro-immune connection, Int. J. Neurosci., 59, 1, 10.3109/00207459108985446 · DOI · Paper page

Cited by

See all 259

Metadata

Authors
McKenna, F., McLaughlin, P. J., Lewis, B. J., Sibbring, G. C., Cummerson, J. A., Bowen-Jones, D., & Moots, R. J.
Venue
Journal of Neuroimmunology
Publisher
Elsevier BV
Published
2002-11
Volume
132
Issue
1-2
Pages
34-40
ISSN
0165-5728
DOI
10.1016/s0165-5728(02)00280-1
Cited by
259
References
0
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Dopamine receptor expression on human T- and B-lymphocytes, monocytes, neutrophils, eosinophils and NK cells: a flow cytometric study. https://app.cochat.ai/papers/10.1016/s0165-5728(02)00280-1
The paper
McKenna, F., McLaughlin, P. J., Lewis, B. J., Sibbring, G. C., Cummerson, J. A., Bowen-Jones, D., & Moots, R. J. (2002). Dopamine receptor expression on human T- and B-lymphocytes, monocytes, neutrophils, eosinophils and NK cells: a flow cytometric study. Journal of Neuroimmunology. https://doi.org/10.1016/s0165-5728(02)00280-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.